Deleobuvir (sodium)
Deleobuvir sodium (BI 207127 sodium) is a non-nucleoside hepatitis C virus NS5B polymerase inhibitor with anti-hepatitis C virus activity[1].
Product Specifications
CAS Number
1370023-80-5
Product Name Alternative
BI 207127 (sodium)
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/deleobuvir-sodium.html
Smiles
CN1C(C2=NC=C(Br)C=N2)=C(C3CCCC3)C4=CC=C(C(NC5(C(N(C6=C7)C)=NC6=CC=C7/C=C/C(O[Na])=O)CCC5)=O)C=C41
Molecular Formula
C34H32BrN6NaO3
Molecular Weight
675.55
References & Citations
[1]Contribution of Major Metabolites toward Complex Drug-Drug Interactions of Deleobuvir: In Vitro Predictions and In Vivo Outcomes
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog